BioCrossroads Heads to the West Coast to Partner With San Diego on Biotech/Pharma Conference.Conference to Look at New Ways of Advancing U.S. Competitiveness; First Collaboration of Its Kind INDIANAPOLIS -- The cost of bringing a new drug to market is currently estimated at $1 billion, making it more critical than ever for the biotechnology and pharmaceutical industries to improve productivity, efficiency and innovation. BioCrossroads, Indiana's initiative to help grow and develop life science companies, and CONNECT, San Diego's non-profit organization A non-profit organization (abbreviated "NPO", also "non-profit" or "not-for-profit") is a legally constituted organization whose primary objective is to support or to actively engage in activities of public or private interest without any commercial or monetary profit purposes. dedicated to creating and sustaining the growth of innovative technology and life science businesses, have created a unique collaboration by sponsoring a biopharmaceutical conference at The Salk Institute for Biological Studies The Salk Institute for Biological Studies is an independent, non-profit, scientific research laboratory located in La Jolla, California. It was founded in 1960 by Jonas Salk, M.D., the developer of the polio vaccine. in La Jolla La Jolla (lə hoi`yə), on the Pacific Ocean, S Calif., an uninc. district within the confines of San Diego; founded 1869. The beautiful ocean beaches, in particular La Jolla shores and Black's Beach, and sea-washed caves attract visitors and , CA on Wednesday, May 30, 2007. The summit is designed to discuss how to bring new discoveries of drugs to market more quickly and more cost-effectively and how to share the risk of these challenges through regional collaborations. San Diego San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. and Indiana are natural partners to present a forum to identify resources to strengthen the U.S.'s competitive advantage within the industry. San Diego has long been regarded as the birthplace of biotech in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . And one topic for discussion is how San Diego's discovery "cluster" of biotech firms can work with universities and companies in Indiana that are well-suited for their needs. Not only is Indiana home to some major players in the biotech/pharma industry such as Eli Lilly and Company Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical company and one of the world's largest corporations. Eli Lilly's global headquarters is located in Indianapolis, Indiana, in the United States. and Cook Pharmica, but it is also home to nearly 30 companies, including contract research organizations, cold storage facilities, contract manufacturing companies, and others that can directly support the continued growth of the nation's biotechnology industry. "The collaboration between BioCrossroads and CONNECT is a powerful one," said David Johnson David Johnson may refer to:
In 2006, Indiana was identified as one of the nation's top four life sciences leaders as defined by the number and concentration of life sciences-related job, according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. the report, "Growing the Nation's Bioscience Sector: State Bioscience Initiatives 2006". A follow-up report, issued earlier this year, said that the Indianapolis Metropolitan Statistical Area (MSA (Metropolitan Service Area) An urban area with at least 50,000 people plus surrounding counties. There are 306 MSAs and 428 RSAs (rural service areas) in the U.S. MSAs and RSAs are used to allocate cellular licenses. ) is home to 24,051 bioscience jobs, ranking ninth in the nation. Four panels will be presented focusing on the discovery, definition, development and delivery of biotech products/pharmaceuticals. David Johnson will moderate one of the panels. Other Indiana-based panel participants include: * Darren Carroll, Senior Managing Director Eli Lilly and Company * Lynn Kippenhan, Global Vice President - Sales, Marketing & Commercial Development Covance Central Laboratory Services * Jack Bailey For the English cricketer, see . Jack Bailey (September 15, 1907 in Hampton, Iowa – February 1, 1980 in Santa Monica, California) was an American actor and the host of the game show Queen for a Day. He also hosted Truth or Consequences from 1954-55. , Vice President - Business to Business Division Eli Lilly and Company * Craig Davis, Ph.D., Director The Chao Center for Industrial Pharmacy and Contract Manufacturing at Purdue University * Dan Peterson, Vice President - Industry & Government Affairs Cook Group Inc. The invitation-only conference will draw approximately 200 attendees, most from the San Diego area. The discussion and conclusions drawn from the conference will enable BioCrossroads to continue to refine its Biotechnology Development and Manufacturing Initiative. To learn more visit: http://www.biocrossroads.com/Content/Content.aspx?Content_ID=34 About BioCrossroads BioCrossroads (www.biocrossroads.com) is Indiana's life science initiative, a public-private collaboration that supports the region's research and corporate strengths while encouraging new business development. BioCrossroads provides money and support to life sciences businesses, launches new life sciences businesses, expands collaboration and partnerships among Indiana's life science institutions, expands science education and markets Indiana's life sciences industry. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion